|
2022
|
Invention
|
Use of 4-arylaminoquinazoline hydroxamic acid compounds in preparation of pain drug. Disclosed is... |
|
2021
|
Invention
|
Salt form and crystal form of compound as smo inhibitor, and preparation method therefor. Disclos... |
|
2020
|
Invention
|
Quality control method for carbocisteine raw material and formulation thereof, and use thereof. D... |
|
2018
|
Invention
|
Salt form and crystal form of compound as fgfr4 inhibitor and preparation method thereof. The pre... |
|
2017
|
Invention
|
Biphenyl compound as ccr2/ccr5 receptor antagonist. Provided is a CCR2/CCR5 receptor antagonist a... |
|
|
Invention
|
Fgfr4 inhibitor and preparation method and use thereof. Provided are a class of compounds as show... |
|
2016
|
Invention
|
Medical use of hydroxyl purine compound. Disclosed in the present invention is an application of ... |
|
|
Invention
|
Crystal form of 4h-pyrazolo[1,5-α]benzoimidazole compound, preparation method therefor and interm... |
|
|
Invention
|
Salt form and crystal form of quinoline derivative, preparation method therefor, and intermediate... |
|
|
Invention
|
Hydroxyl purine compounds and use thereof. Disclosed are a series of hydroxyl purine compounds an... |
|
|
Invention
|
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor. Disclosed is a fused-r... |
|
|
Invention
|
Tyrosine kinase inhibitor and pharmaceutical composition comprising same. The present invention r... |
|
|
Invention
|
Histone deacetylase inhibitor, and preparation method and use thereof. A compound represented by ... |
|
2015
|
Invention
|
Hydroxyl purine compounds and applications thereof. Hydroxyl purine compounds represented by form... |
|
|
Invention
|
Quinoline derivatives as smo inhibitors. Disclosed are quinoline derivatives as hedgehog pathway ... |
